P

Pegavision Corp
TWSE:6491

Watchlist Manager
Pegavision Corp
TWSE:6491
Watchlist
Price: 282 TWD -1.57% Market Closed
Market Cap: NT$22B

Pegavision Corp
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pegavision Corp
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
P
Pegavision Corp
TWSE:6491
Gross Profit
NT$3.7B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
N/A
M
Medtecs International Corporation Ltd
SGX:546
Gross Profit
$12.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Visco Vision Inc
TWSE:6782
Gross Profit
NT$1.9B
CAGR 3-Years
16%
CAGR 5-Years
28%
CAGR 10-Years
N/A
SciVision Biotech Inc
TWSE:1786
Gross Profit
NT$638.4m
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
15%
OK Biotech Co Ltd
TWSE:4155
Gross Profit
NT$442.9m
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Pegavision Corp
Glance View

Market Cap
22B TWD
Industry
Health Care

Pegavision Corp. focusing on research, development, manufacture and marketing of soft contact lenses and the medical optic devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2014-12-30. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
335.13 TWD
Undervaluation 16%
Intrinsic Value
Price NT$282
P

See Also

What is Pegavision Corp's Gross Profit?
Gross Profit
3.7B TWD

Based on the financial report for Dec 31, 2025, Pegavision Corp's Gross Profit amounts to 3.7B TWD.

What is Pegavision Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
13%

Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Pegavision Corp have been 4% over the past three years , 13% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett